Acelrx pharmaceuticals inc

Major-Pharmaceuticals

ACRX


351 Galveston Drive
Redwood City , CA 94063

Executive/
Director

Price

  • Last Close
  • $ 0.7
    $ +0.05 7.69 %
    Dec 6, 2024
  • 52-Week High/Low
  • $1.5 - $0.45
  • YTD
  • -4.8%

  • Trading Volume
  • 100
  • Market Cap Full
  • $ 11.9M
  • Shares Outstanding
  • 17M
    Nov 3, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -42.6% -20% 21.2% 3.5% 50.7% -5% 37.1% -48.2% -70.9% 40.1%
Q2 9.8% -12.7% -31.8% 58.7% -31.3% 4% -18.8% -17.2% 68.7% -8.2%
Q3 -28.1% 44.6% 114% 12.2% -10.3% 8% -26.1% 1650% -47.8% -
Q4 26.2% -33.2% -63.1% -39.5% -4.1% -12.7% -45.1% -46.2% 33.6% -
J F M A M J J A S O N D
2024 41.5% 30.8% -24.3% -4.7% - - - - - - - -
2023 -11.5% -29% -53.7% 1.8% 48.7% 11.5% -7.2% - -43.7% -10.3% 41.4% -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    -40%-43%-32%-22%14%-8%-41%-55%304%-67%-5%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022
Q1 0.27 0.22 0.34 -0.23 -0.17 -0.2 -0.08 -1.2
Q2 0.20 0.24 0.29 -0.2 -0.16 -0.08 -0.08 9.6
Q3 0.11 0.25 0.28 -0.21 -0.16 -0.1 -0.07 -0.94
Q4 0.24 0.21 0.20 -0.17 -0.18 -0.09 -1.26 -1.74
A 0.8 0.9 1.1 -0.8 -0.7 -0.5 -5.9 5.7

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 78.8 80.4 118.9 146.9 10.9
Jun 51.3 78.9 80.8 119.1 147.1 10.9
Sep 60.6 79.4 90.3 119.2 147.3 16.3
Dec 61.9 79.6 90.5 119.3 7.4 17

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 3 4 3 2.3 4
Fixed Asset Turnover 0.1 0.2 0.3 0.1 0.2
Total Asset Turnover - - 0.1 - -
Leverage
Debt Ratio - 0.1 0.3 0.3 -
Debt – Equity Ratio - -0.1 -0.2 -0.5 0.8
Interest Coverage 0.4 36 41 54 -3.3
Equity multiplier 0.9 -0.5 -0.3 -0.4 3